Effects of Tomato Sauce on Endothelial Dysfunction Induced by a High Fat Meal in Healthy Subjects
VRPM
1 other identifier
interventional
19
1 country
1
Brief Summary
Several epidemiological and intervention studies suggest that a high dietary intake of tomatoes is associated with lower risk of cardiovascular disease (CVD), while, low intake is associated with an increased incidence of CVD. This beneficial effects have been attributed especially to lycopene, an antioxidant present in high concentration within tomatoes but other substances could be of importance. Endothelial dysfunction is an early marker of atherosclerosis leading to CVD. The aim of the present study is therefore to investigate whether consumption of tomato products ameliorates peripheral endothelial function, triggered by a high fat meal, in human volunteers in a randomised, crossover dietary intervention study. Study design: Investigators are randomising healthy men (N=14-28) to consume a high fat meal either with or without tomato sauce (80 gr) in a cross-over design with a 7 days wash-out period. During the week before the study all the subjects will be maintained in a low fibers diet and only subjects randomized to tomatoes will receive a daily dose of 80 mg of tomato sauce (80 gr for 7 days= total load 560 mg). We hypothesize that tomato sauce can improve the deleterious effects of a high fat meal on vascular function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 16, 2013
CompletedFirst Posted
Study publicly available on registry
October 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedApril 16, 2019
April 1, 2019
2.2 years
October 16, 2013
April 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Flow Mediated Dilatation (FMD)
Endothelial function as measured non-invasively by ultrasound (LogiQ P5 pro, GE Healthcare) using the "Flow Mediated Dilatation" (FMD) technique with the aid of a dedicated hardware (Multimedia Video Engine II (MVE2) DSP Lab., Pisa CNR, Italy).
change in FMD 2 and 3.5 hour after a high fat meal
Secondary Outcomes (3)
Arterial stiffness measured as Stiffness Index (SI), Carotid distensibility (CD)
change in SI and CD 2 and 3.5 hour after a high fat meal
inflammatory cytokines
chnage in inflammatory cytokines 2 and 3.5 hour after a high fat meal
blood pressure
change in blood pressure 2 and 3.5 hour after a high fat mealeal
Other Outcomes (2)
plasma level of lycopene and other substances contained in tomatoes.
change 2 and 3.5 hour after a high fat meal
glucose and lipid
change 2 and 3.5 hour after a high fat meal
Study Arms (2)
tomato sauce (+/- high fat meal)
ACTIVE COMPARATOR80 gr for 7 days= total load 560 mg (+/- high fat meal)
diet without tomato (+/- high fat meal)
PLACEBO COMPARATORdiet without tomato (+/- high fat meal)
Interventions
We are randomising healthy men (N=14-28) to consume a high fat meal either with or without tomato sauce (80 gr) in a cross-over design with a 7 days wash-out period. During the week before the study, all the subjects will be maintained in a low fibers diet and only subjects randomized to tomatoes will receive a daily dose of 80 mg of tomato sauce (80 gr for 7 days= total load 560 mg).
Eligibility Criteria
You may qualify if:
- Healthy men,
You may not qualify if:
- age range 28 ±10 years;
- BMI between 19-27 Kg/m2
- Previous cardiovascular events, kidney failure (serum creatinine ≥1,5 mg/dl), arterial blood pressure ≥140/90mmHg or diagnosed hypertension; chronic inflammatory or neoplastic diseases, diabetes mellitus or impaired fasting glucose (glucose ≥110 mg/dL), hypercholesterolemia (total cholesterol ≥240 mg/dl or anti-lipemic medication use), current smoking, antihypertensive medications; use of antioxidant drugs or NSAIDs or COXIBs; food allergy to tomato or other components of the high fat diet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Verona
Verona, 37134, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Cristiano Fava, M.D.; PhD
Universita di Verona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
October 16, 2013
First Posted
October 24, 2013
Study Start
October 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
April 16, 2019
Record last verified: 2019-04